RadNet delivered strong Q4 2024 results with revenue rising 13.5% to $477.1 million. Adjusted EPS improved to $0.22, reflecting operational efficiency and strategic investments. The company saw an 8.0% increase in procedural volumes, including double-digit growth in MRI, CT, and PET/CT scans. Cash reserves surged to $740 million, positioning RadNet well for future expansion.
Total revenue increased 13.5% year-over-year to $477.1 million.
Adjusted EPS rose to $0.22 from $0.15 in Q4 2023.
Digital Health revenue surged 28.1% to $18.9 million.
Cash balance grew to $740 million, reflecting strong financial health.
RadNet anticipates continued growth in 2025, supported by increased procedural volumes, strategic acquisitions, and expanded digital health offerings.
Analyze how earnings announcements historically affect stock price performance